Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Lymphoma, Large B-Cell, Diffuse 23Burkitt Lymphoma 14Sarcoma 13Neoplasms 11Lymphoma, Follicular 11Lymphoma 10Hodgkin Disease 9Breast Neoplasms 9Triple Negative Breast Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Non-Hodgkin 8Endometrial Neoplasms 8Ovarian Neoplasms 7Lymphoma, B-Cell 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5Wilms Tumor 4Recurrence 4Osteosarcoma 4Neoplasm Metastasis 4Liposarcoma 4Fallopian Tube Neoplasms 4Sarcoma, Ewing 3Neuroblastoma 3Lymphoproliferative Disorders 3Lymphoma, T-Cell 3Lymphoma, Mantle-Cell 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia, Biphenotypic, Acute 3Leiomyosarcoma 3

Interventions

Mitomycin 3Oxaliplatin 2Fluorouracil 2sodium thiosulfate 1nilotinib 1Paclitaxel 1Leucovorin 1Laparoscopy 1Electrocardiography 1Doxorubicin 1Cisplatin 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Appendiceal Neoplasms × Doxorubicin × 90 days × Clear all
NCT04847063 2026-04-14

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
60 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Gastrointestinal Neoplasms, Necrosis, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡